Therefore, the focus of this study was to explore the specific molecular mechanism by which IL-8, which is highly expressed in HNSCC under conditions of glucose deficiency, enhances tumor cell resistance to glucose deficiency and to provide new therapeutic ideas to address drug resistance in nutrient-starvation therapy. The gene discussed is CXCL8; the disease is head and neck squamous cell carcinoma.